Two speakers argue that AI companies like Anthropic use promises to cure disease as marketing cover for rapid development. They claim firms get a free pass to build faster in exchange for public commitments to solving biomedical problems, turning a genuine goal into corporate strategy.
Chapters
There is a business model for curing all human disease that's actually better than pharma. Just like orbital data centres were ultimately the business model for developing the solar system, there is now a better business model in town for curing all human disease, and that is as marketing for not slowing down recursive self-improvement.
Yes, 100%, right? You can't slow down the company curing cancer. You can't slow down the company doubling our human lifespan.
Anthropic and And Dario have— I mean, again, reading between the lines of his announcement, the offer, the quid pro quo is let us not slow down our recursive self-improvement, in return for which, as a marketing effort, we will cure all human disease. That's the new better business model for curing all human disease.
I believe he truly believes this, right? Yes, well, of course.
But that, that— I think that's the implicit quid pro quo now.